Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc.

TCMD·NASDAQ

$24.37

-0.16%
HealthcareMedical - Devices

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

At a Glance

Live Snapshot
Market Cap$549.70M
EPS0.8300
P/E Ratio29.36
Earnings Date08/03/2026

tcmd

Accounts Receivables

Last Annual Value

43.88M

3-Year CAGR

-7%

5-Year CAGR

%

10-Year CAGR

12%

Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc. Competitors Analysis of Accounts Receivables

TCMD · NASDAQ
CompanyAccounts Receivables
CAGR 3Y
CAGR 5Y
CAGR 10Y
43.88M
0.5%-2.4%11.3% 
SRDX logo
Surmodics, Inc.
NASDAQ:SRDX
23.16M
7.5%7.3%12.9%
11.74M
265.3%205.7%40.1%
NPCE logo
NeuroPace, Inc.
NASDAQ:NPCE
14.68M
6.0%15.7%N/A
CBLL logo
CeriBell, Inc.
NASDAQ:CBLL
15.05M
23.7%N/AN/A
53.84M
15.9%24.6%29.4%
25.59M
11.5%14.8%18.2%
4.38M
-10.6%3.9%17.4%
26.74M
25.8%17.5%N/A
RXST logo
RxSight, Inc.
NASDAQ:RXST
23.38M
4.9%36.9%N/A
Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc. Fair Value Envelope

TCMD · NASDAQ

Our analysis suggests that TCMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $24.37, this represents a potential HIDDEN relative to our calculated worth for Tactile Systems Technology, Inc..

Intrinsic Value
Current Price: $24.37